Skip to main content

The pathophysiology of peptic ulcer disease

Digestive Diseases and Sciences volume 30, pages 15S–29S (1985)Cite this article

Abstract

Heterogeneity is the most important consideration in the pathophysiology of peptic ulcer disease. Acute ulcers and erosions present clinically with gastrointestinal bleeding or perforation. if they heal there is no predictable recurrence. Factors concerned with mucosal defense are relatively more important than aggressive factors such as acid and pepsin. Local ischemia is the earliest recognizable gross lesion. The gastric mucosa is at least as vulnerable as the duodenal mucosa and probably more so. Most drug-induced ulcers occur in the stomach. Chronic or recurrent true peptic ulcers (penetrating the muscularis mucosae) usually present with abdominal pain. Many duodenal ulcer patients report that the pain occurs when the stomach is empty or is relieved by food, and follows a pattern of relatively long periods of freedom from symptoms between recurrences. Approximately 50% of patients experience a recurrence within a year if anti-ulcer medication is stopped. In most western countries recurrent duodenal ulcer is more common than gastric ulcer. Peptic ulcer disease is also more common in men. Recent evidence indicates genetic and familial factors in duodenal ulcer and increased acidpepsin secretion in response to a variety of stimuli. However, it is also becoming clear that of all the abnormal functions noted, few are present in all subjects and many are clustered in subgroups. In chronic gastric ulcer of the corpus, defective defense mechanisms, such as duodenogastric reflux and atrophic gastritis, seem to be more important than aggressive factors. Nevertheless, antisecretory medications accelerate the healing of such ulcers. It remains to be seen whether prostaglandins, mucus secretion, or gastric mucosal blood flow are impaired in chronic ulcer disease.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Brooks FP: The pathophysiology of peptic ulcer: An overview.In Peptic Ulcer, New York, Churchill Livingstone, in press, pp 51–60

  2. Sava G: Ulcérations et ulcère aigus de l'estomac. France Medicale 30:274, 1967

    Google Scholar 

  3. Hunt PS, Korman MG, Hansky J, Schmidt GT, Hillman HS: Acute gastric ulceration: A prospective study of incidence and results of management. Aust NZ J Med 10(3):305–308, 1980

    Google Scholar 

  4. Davenport HW: Salicylate damage to the gastric mucosal barrier. N Engl J Med 276:1307–1312, 1967

    Google Scholar 

  5. Davenport HW: Gastric mucosal injury by fatty acid and acetylsalicylic acids. Gastroenterology 46:245–253, 1965

    Google Scholar 

  6. Munro DR: Route of protein loss during a model proteinlosing gastropathy in dogs. Gastroenterology 66:960–972, 1974

    Google Scholar 

  7. Davenport HW, Kauffman GL Jr: Plasma shedding by the canine. Oxyntic and pyloric glandular mucosa induced by topical action of acetylcholine. Effect of atropine and physostymine. Gastroenterology 69:190–197, 1975

    Google Scholar 

  8. Wood JG, Davenport HW: Measurement of canine vascular permeability to plasma proteins in the normal and protein-losing states. Gastroenterology 82:725–733, 1982

    Google Scholar 

  9. Geall MG, Phillips SF, Summerskill WHJ: Profile of gastric potential difference in man: Effects of aspirin, alcohol, bile and endogenous acid. Gastroenterology 58:437–443, 1970

    Google Scholar 

  10. Murray HS, Strottman MP, Cooke AR: Effect of several drugs on gastric potential difference in man. Br Med J 1:19–21, 1974

    Google Scholar 

  11. Morris GP, Wallace JL, Harding PL, Krausse EJ, Lolle SJ: Correlations between changes in indicators of gastric mucosal barrier integrity at time of exposure to “Barrier Breakers” and extent of hemorrhagic erosions one hour later. Dig Dis Sci 29:6–11, 1984

    Google Scholar 

  12. Silen W, Schiessel R, Kivilaakso E: The gastric mucosal barrier and ulceration. Brain Res Bull 5(Suppl 1):3–6, 1980

    Google Scholar 

  13. Kivilaakso E, Bargilai A, Schiessel R, Fromm D, Silen W: Experimental ulceration of rabbit antral mucosa. Gastroenterology 80:77–83, 1981

    Google Scholar 

  14. O'Brien P, Silen W: Influence of acid secretory state on the gastric mucosal tolerance to back diffusion of H+. Gastroenterology 71:760–765, 1976

    Google Scholar 

  15. Kivilaakso E: High plasma HCO3 protects gastric mucosa against acute ulceration in the rat. Gastroenterology 81:921–927, 1981

    Google Scholar 

  16. O'Brien P, Bushnell M: Role of acid-base status in the responses of the isolated amphibian gastric mucosas to back diffusion of H+. Gastroenterology 79:439–445, 1980

    Google Scholar 

  17. Menguy R: Role of gastric mucosal energy metabolism in the etiology of stress ulceration. World J Surg 5:175–179, 1981

    Google Scholar 

  18. Silen W: The prevention and management of stress ulcers. Hosp Pract, March 1980, 15:pp 93–100

    Google Scholar 

  19. Czaja AJ, McAlhany JC, Pruitt BA Jr: Acute gastroduodenal disease after thermal injury: An endoscopic evaluation. N Engl J Med 291:925–928, 1974

    Google Scholar 

  20. Kamada T, Sato N, Kawano S, Fusamoto H, Abe H: Gastric mucosal dynamics after thermal or head injury: A clinical application of reflectance spectrophotometry. Gastroenterology 83:535–540, 1982

    Google Scholar 

  21. Mersereau WA, Hinchey EJ: Effect of gastric acidity on gastric ulceration induced by hemorrhage in the rat utilizing a gastric chamber technique. Gastroenterology 64:1130–1135, 1973

    Google Scholar 

  22. Garner A, Flemström G, Allen A, Heylings JR, McQueen S: Gastric mucosal protective mechanisms: Roles of epithelial bicarbonate and mucus secretions. Scand J Gastroenterol 19(Suppl 101):79–86, 1984

    Google Scholar 

  23. Kauffman GL Jr, Ligumsky M: Role of endogenous prostaglandins in gastric mucosal integrity.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 317–322

    Google Scholar 

  24. Hollander F: The two-component mucus barrier. Arch Intern Med 94:107–120, 1974

    Google Scholar 

  25. Hurst BC, Rees WDW, Garner A: Cell shedding by the stomach and duodenum.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 21–26

    Google Scholar 

  26. Chaudhury TK, Robert A: Prevention by mild irritants of gastric necrosis produced in rats by sodium taurocholate. Dig Dis Sci 25:830–836, 1980

    Google Scholar 

  27. Robert A: Role of endogenous and exogenous prostaglandins in mucosal protection.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 377–382

    Google Scholar 

  28. Ito S, Lacy ER, Rutten MJ, Critchlow J, Silen W: Rapid repair of injured gastric mucosa. Scand J Gastroenterol 19(Suppl 101):87–95, 1984

    Google Scholar 

  29. Robert A: Cytoprotection: What it is and what it is not.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 381–382

    Google Scholar 

  30. Svanes K, Critchlow J, Takeuchi K, Magee D, Ito S, Silen W: Factors influencing reconstitution of frog gastric mucosa: Role of prostaglandins.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg, (eds). New York, Raven Press, 1984, pp 33–39

    Google Scholar 

  31. Lacy ER, Ito S: Ethanol-induced insult to the superficial rat gastric epithelium: A study of damage and rapid repair.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 49–63

    Google Scholar 

  32. Ito S, Lacy ER: Characteristics of ethanol-induced lesions in rat gastric mucosa.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 57–63

    Google Scholar 

  33. Pruitt BA, Foley FD, Moncrief JA: Curling's ulcer: A clinical pathology study of 323 cases. Ann Surg 172: 523–539, 1970

    Google Scholar 

  34. Zach GA, Gyr KE, Alvenslebew E, Mills JG, Stalder GA, Dunn SL, Bloom SA: Double-blind, randomized, controlled study to investigate the efficacy of cimetidine given in addition to conventional therapy in the prevention of stress ulceration and hemorrhage in patients with acute spinal injury. Digestion 29:214–222, 1984

    Google Scholar 

  35. Ivey KJ: Drugs, gastritis, and peptic ulcer. J Clin Gastroenterol 3 (Suppl 2):29–34, 1981

    Google Scholar 

  36. Domschke S, Domschke W: Gastroduodenal damage due to drugs, alcohol and smoking. Clin Gastroenterol 13:405–436, 1984

    Google Scholar 

  37. Rees WDW, Gibbons LC, Warhurst G, Turnberg LA: Studies of bicarbonate secretion by the normal human stomach in vivo: Effect of aspirin, sodium taurocholate, and prostaglandin E2.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 119–123

    Google Scholar 

  38. Silvoso GR, Ivey KJ, Butt JH, Lockard OD, Holt SD, Sisk C, Baskin WN, Mackercher PA, Hewett J: Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 91:517–520, 1979

    Google Scholar 

  39. Carlson D, Gerber E, Weinstein W, Grossman MI, Bluestone R, Guth P: Drug-associated gastroduodenal lesions in rheumatoid arthritis: An endoscopic and histologic study. Gastroenterology 78:1147, 1980

    Google Scholar 

  40. Welch RW, Bantch HL, Harris SC: Reduction of aspirin-induced gastrointestinal bleeding with cimetidine. Gastroenterology 74:459–463, 1978

    Google Scholar 

  41. Muller P, Dammann HG, Simon B, Kommerell B: Prostaglandins and human gastric mucosa: Molecular aspects and protective properties.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 311–316

    Google Scholar 

  42. Stern AI, Hogan DL, Sandersfield MA, Kahn LH, Isenberg JI: Do low doses of 15(R) 15 Methyl-PGE2 (MPGE) prevent aspirin (ASH) induced gastric damage in man? Gastroenterology 84:1325, 1983

    Google Scholar 

  43. Gilbert DA, Surawicz CM, Silverstein FE, Weinberg CR, Saunders DR, Feld AD, Sanford RL, Bergman D, Washington P: Prevention of acute aspirin-induced gastric mucosal injury by 15R-15R methyl prostaglandin E2: An endoscopic study. Gastroenterology 86:339–345, 1984

    Google Scholar 

  44. Hunt JN, Smith JL, Jiang CL, Kessler L: Effect of synthetic prostaglandin E1 analog on aspirin-induced bleeding and secretion. Dig Dis Sci 28:897–902, 1983

    Google Scholar 

  45. Konturek SJ, Kwiecien N, Obtulowicz W, Polanski M, Kopp B, Oleksy J: Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man. Gut 24:89–93, 1983

    Google Scholar 

  46. Graham DY, Smith JL, Dobbs SM: Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 28:1–6, 1983

    Google Scholar 

  47. Tesler MA, Lim ES: Protection of gastric mucosa by sucralfate from aspirin-induced erosions. J Clin Gastroenterol 3(Suppl 2):175–179, 1981

    Google Scholar 

  48. Palmer ED: Gastritis: A Revaluation. Medicine 33: 199–280, 1954

    Google Scholar 

  49. Brosinne A: Effects of ethanol on plasma protein shedding in the human stomach. Dig Dis Sci 24:44–47, 1979

    Google Scholar 

  50. Ivey KJ, Den Besten L, Clifton JA: Effect of bile salts on ionic movement across the human gastric mucosa. Gastroenterology 59:683–690, 1970

    Google Scholar 

  51. Duane WC, Wiegand DM, Gilberstadt ML: Intragastric duodenal lipids in the absence of a pyloric sphincter: Quantitation, physical state, and injurious potential in the fasting and post prandial states. Gastroenterology 78: 1480–1487, 1980

    Google Scholar 

  52. Fimmel CJ, Müller-Lissner SA, Blum AL: Acute bile salt-induced mucosal damage in man: Time course and effect of misoprostol a PGE1-analogue.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 341–349

    Google Scholar 

  53. Skillman JJ, Bushell LS, Goldman H, Silen W: Respiratory failure, hypotension, sepsis, and jaundice: A clinical syndrome with lethal hemorrhage from acute stress ulceration of the stomach. Am J Surg 117:523–530, 1969

    Google Scholar 

  54. Skillman JJ, Gould SA, Chung RSK, Silen W: The gastric mucosal barrier: Clinical and experimental studies in critically ill and normal man and in the rabbit. Ann Surg 172:564–584, 1970

    Google Scholar 

  55. Fiddian-Green RJ, McGough E, Pittenger G, Rothman E: Prediction value of intramural pH and other risk factors for massive bleeding from stress ulceration. Gastroenterology 85:613–620, 1983

    Google Scholar 

  56. Lucas CE, Sugawa C, Friend W, Walt AS: Therapeutic implications of disturbed gastric physiology in patients with stress ulceration. Am J Surg 123:25–34, 1972

    Google Scholar 

  57. Weiss JB, Peskin GW, Isenberg JI: Treatment of hemorrhagic gastritis with 15(R)-15 methyl prostaglandin E2: Report of a case. Gastroenterology 82:558–560, 1982

    Google Scholar 

  58. Smith FH, Jordan SM: Gastric ulcer: A study of 600 cases. Gastroenterology 11:575–597, 1948

    Google Scholar 

  59. Flood CA, Hennig GC: Recurrence in gastric ulcer under medical management. Gastroenterology 16:57–72, 1950

    Google Scholar 

  60. Smith FH, Boles RS Jr, Jordan SM: Problems of the gastric ulcer reviewed—Study of one thousand cases. JAMA 153:1505–1508, 1953

    Google Scholar 

  61. The Veterans Administration co-operative study on gastric ulcer. Gastroenterology 61:561–564, 1971

    Google Scholar 

  62. Halse SA, Kristensen E, Moller-Jensen O, Morkbak NK: Prognosis of medically treated gastric ulcer. Scand J Gastroenterol 12:489–495, 1977

    Google Scholar 

  63. Piper DW, Shinners J, Greig M, Thomas J, Waller SL: Effect of ulcer healing on the prognosis of chronic gastric ulcer. Gut 19:419–424, 1978

    Google Scholar 

  64. Miyake T, Ariyoshi J, Suzaki T, Oishi M, Sakai M, Ueda S: Endoscopic evaluation of the effect of sucralfate therapy and other clinical parameters on the recurrence rate of gastric ulcers. Dig Dis Sci 25:1–7, 1980

    Google Scholar 

  65. Wright JP, Kahavovitz C, Marks IN: Gastric ulceration: A follow-up study. S Afr Med J 60 (16):611–612, 1981

    Google Scholar 

  66. Gertler S, Isenberg J, Elashoff J, Reedy T, Sandersfield M, Peterson W: Gastric ulcer recurrence following medical healing. Gastroenterology 84:1164, 1983

    Google Scholar 

  67. Jensen KB, Mollman K-M, Rabbek I, Madsen JR, Rune SJ, Wolff HR: Prophylactic effect of cimetidine in gastric ulcer patients. Scand J Gastroenterol 14:175–176, 1979

    Google Scholar 

  68. Alstead EM, Ryan FP, Holdsworth CD, Ashton MG, Moore M: Ranitidine in the prevention of gastric and duodenal ulcer relapse. Gut 24:418–420, 1983

    Google Scholar 

  69. Barr GD, Kang JY, Canalese J, Piper DW: A two-year prospective controlled study of maintenance cimetidine and gastric ulcer. Gastroenterology 85:100–104, 1983

    Google Scholar 

  70. Hentschel E, Schultze K, Weiss W, Rudiger E, Judmaci G, Reichel W, Kerstan E, Horton J: Effect of cimetidine treatment in the prevention of gastric ulcer relapse: A one year double blind multicentre study. Gut 24:853–856, 1983

    Google Scholar 

  71. Mowat NAG, Needham CD, Brunt PW: The natural history of gastric ulcer in a community: A four-year study. Quart J Med 44:45–56, 1975

    Google Scholar 

  72. Johnson HD: The classification and principles of treatment of gastric ulcers. Lancet 2:518–520, 1957

    Google Scholar 

  73. Oi M, Oshida K, Sugimura S: The location of gastric ulcer. Gastroenterology 36:45–56, 1959

    Google Scholar 

  74. Kirkpatrick JR, Lawrence JH, Forrest APM, Campbell H: The short pentagastrin test in the investigation of disease. Gut 10:760–762, 1969

    Google Scholar 

  75. Chapman MA, Werther JL, Janowitz HD: Response of the normal and pathological human gastric mucosa to an instilled acid load. Gastroenterology 55:344–353, 1968

    Google Scholar 

  76. Ornsholt J, Amdrup E, Andersen D, Hostrup H: Arhus county (Denmark) vagotomy trial: Acid secretory patterns in patients with prepyloric, pyloric and duodenal ulcer. Digestion 26(3):146–152, 1983

    Google Scholar 

  77. Schlegel W, Wenk K, Dollinger HC, Raptis S: Concentrations of prostaglandin A-, E- and F-like substances in gastric mucosa of normal subjects and of patients with various gastric diseases. Clin Sci Mol Med 52:255–258, 1977

    Google Scholar 

  78. Wright JP, Young GO, Klaff LJ, Weers LA, Price SK, Marks IN: Gastric mucosal prostaglandin E levels in patients with gastric ulcer disease and carcinoma. Gastroenterology 82:263–267, 1982

    Google Scholar 

  79. Kobayashi K, Arakawa T, Nakamura H, Yamamoto S: An endoscopic study on the mucosal prostaglandin level in patients with peptic ulcer. World Congress of Gastroenterology, Stockholm, 1982, Abstr. 108

  80. Garrett JM, Summerskill WHJ, Code CF: Antral motility in patients with gastric ulcer. Am J Dig Dis 11:780–789, 1966

    Google Scholar 

  81. Miller LS, Malagelada JR, Longstreth GF, Go VLW: Dysfunction of the stomach with gastric ulceration. Dig Dis Sci 25:857–864, 1980

    Google Scholar 

  82. Fisher RS, Cohen S: Pyloric-sphincter dysfunction in patients with gastric ulcer. N Engl J Med 288:274–276, 1973

    Google Scholar 

  83. Müller-Lissner SA, Fimmel CJ, Sonnenberg A, Will N, Midler-Duysing W-M, Heinzel F, Muller R, Blum AL: Novel approaches to quantify duodenogastric reflux in healthy volunteers with type I gastric ulcer. Gut 24:510–518, 1983

    Google Scholar 

  84. Janowitz HD: Bile in the stomach: Gastroenterology 57:356–357, 1969, Editorial comment

    Google Scholar 

  85. Alexander-Williams J, Wolverson RL: Pathogenesis and pathophysiology of gastric ulcer. Clin Gastroenterol 13:601–619, 1984

    Google Scholar 

  86. Fukutomi H, Yamagata J, Takase Y, Takao S: Endoscopical measurement of gastric blood flow of the patients with gastric ulcer. World Congress of Gastroenterology, Stockholm, 1982, Abstr. 777

  87. Kamada T, Kawano S, Sato N, Fukuda M, Fusamoto H, Abe H: Gastric mucosal blood distribution and its changes in the healing process of gastric ulcer. Gastroenterology 84:1541–1546, 1983

    Google Scholar 

  88. Thomas J, Greig M, Piper DW: Chronic gastric ulcer and life events. Gastroenterology 78:905–911, 1980

    Google Scholar 

  89. Peters MN, Richardson CT: Stressful life events, acid hypersecretion and ulcer disease. Gastroenterology 84:114–119, 1983

    Google Scholar 

  90. Isenberg JI, Peterson WL, Elashoff JD, Sandersfield MA, Reedy TJ, Ippoliti AF, Van Deventer GM, Franki H, Longstreth FG, Anderson DS: Healing of benign gastric ulcr with low-dose antacid or cimetidine: A double-blind, randomized, placebo-controlled trial. N Engl J Med 308:1319–1323, 1983

    Google Scholar 

  91. Kellow JE, Barr GD, Cowen AE, Ward M, Wood L, Piper DW: Comparison of ranitidine and cimetidine in the treatment of chronic gastric ulcer. Digestion 27:105–110, 1983

    Google Scholar 

  92. Barbara L, Corinaldesi R, Dobrilla G, Defretis G, Bianchi Porro G, Parada A, Currata R, Paoluzi P, Mazzacca G, Sabbatini F, Scuro LA, Civallini G, Verne G, Pera A: Ranitidine vs cimetidine short term treatment of gastric ulcer. Hepato-gastroenterology 30:151–153, 1983

    Google Scholar 

  93. La Brooy S, Taylor R, Hunt R, Golding T, Laidlaw J, Chapman R, Founder R, Vincent S, Colin-Jones D, Milton-Thompson G, Misiewicz J: Controlled comparison of cimetidine and carbenoxolone sodium in gastric ulcer. Br Med J 1:1308–1309, 1979

    Google Scholar 

  94. Sutton DR: Gastric ulcer healing with tripotassium dicitrito bismuthate and subsequent relapse. Gut 23:621–624, 1982

    Google Scholar 

  95. Morgan AG, McAdam WAF, Pacsoo C, Darnborough A: Comparison between cimetidine and caved-S in the treatment of gastric ulceration and subsequent maintenance therapy. Gut 23:545–551, 1982

    Google Scholar 

  96. Nagashima R: Mechanisms of action of sucralfate. J Clin Gastroenterol 3 (Suppl 2):117–127, 1981

    Google Scholar 

  97. Tytgat GNJ, Hameeteman W, Olffen GH: Sucralfate, bismuth compounds, substituted-benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer. Clin Gastroenterol 13:543–568, 1984

    Google Scholar 

  98. Rybicka J, Gibinski K: Methyl-prostaglandin E2 analogs for healing of gastro-duodenal ulcers. Scand J Gastroenterol 13:155–160, 1978

    Google Scholar 

  99. Valnes K, Myren J, Ovigstad T: Trimipramine in the treatment of gastric ulcer. Scand J Gastroenterol 13: 497–500, 1978

    Google Scholar 

  100. Black RB, Rhodes J, Davies GT, Gravelle H, Sweetnam P: A controlled clinical trial of cholestyramine in the treatment of gastric ulcer. Gastroenterology 61:821–825, 1971

    Google Scholar 

  101. Kelly KA, Malagelada J-R: Medical and surgical treatment of chronic gastric ulcer. Clin Gastroenterol 13:621–634, 1984

    Google Scholar 

  102. Doll R, Pygott F: Factors influencing the rate of healing of gastric ulcer: Admission to hospital, phenobarbitone and ascorbic acid. Lancet 1:171–175, 1952

    Google Scholar 

  103. Piper DW, Hunt J, heap TR: The healing rate of chronic gastric ulcer in patients admitted to hospital. Scand J Gastroenterol 15:113–117, 1980

    Google Scholar 

  104. Herrmann RP, Piper DW: Factors influencing the healing rate of chronic gastric ulcer. Am J Dig Dis 18:1–6, 1973

    Google Scholar 

  105. James O, Kenefick JS: Pain in gastric ulcer. Lancet 1:562, 1974

    Google Scholar 

  106. Feldman M: Neural and hormonal factors in peptic ulcer disease. J Clin Gastroenterol 3 (Suppl 2):51–56, 1981

    Google Scholar 

  107. Feldman M, Richardson CT, Fordtran JS: Sham feeding in DU patients. Letter to editor. Gastroenterology 79:1353–1354, 1980

    Google Scholar 

  108. Lam SK, Lai CL, Lee NW, Fok KH, Ng M, Siv KF, Wong J: Effective healing of duodenal ulcer with single night time dose of oxmetidine: A double-blind controlled study. Gastroenterology 85:1221, 1983

    Google Scholar 

  109. Gledhill T, Howard OM, Buck M, Paul A, Hunt RH: Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer. Gut 24:904–908, 1983

    Google Scholar 

  110. McCloy RF, Greenberg GR, Baron JH: Duodenal pH in health and duodenal ulcer disease. Gut 25:386–392, 1984

    Google Scholar 

  111. Malagelada J-R, Longstreth GF, Deering TB, Summerskill WHJ, Go VLW: Gastric secretion and emptying after ordinary meals in duodenal ulcer. Gastroenterology 73:992, 1977

    Google Scholar 

  112. Morrissey SM, Ward PM, Jayaraj AP, Tobey FI, Clark CG: Histochemical changes in mucus in duodenal ulceration. Gut 24:909–913, 1983

    Google Scholar 

  113. Olsen PS, Pedersen JH, Kirkegaard P, Been H, Stadil F, Fahrenkrug J, Christiansen J: Neurotensin induced inhibition of gastric acid secretion in duodenal ulcer patients before and after parietal cell vagotomy. Gut 25:481–484, 1984

    Google Scholar 

  114. Coluti TJ, Unger RH, Feldman M: Role of circulating somatostatin in regulation of gastric acid secretion, gastric release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients. J Clin Invest 74:417–423, 1984

    Google Scholar 

  115. Christiansen J, Kirkegaard P, Olsen PS, Petersen B: Interaction of calcium and gastrin on gastric acid secretion in duodenal ulcer patients. Gut 25:174–177, 1984

    Google Scholar 

  116. Lorenz W, Troidl H, Barth H, Rohoe H, Schulz S, Becker H, Dormann P, Schmal A, Kusche J, Meyer R: Stimulusecretion coupling in the human and canine stomach: Role of histamine.In Stimulus Secretion Coupling in the Gastrointestinal Tract, RM Case, H Goebell (eds). Lancaster, England, MTP Press, 1975, p 177

    Google Scholar 

  117. Dubey P, Kundy S: Simultaneous measurement of gastric and duodenal alkali secretion by in situ titration in health and disease. Gut 24:1126–1129, 1983

    Google Scholar 

  118. Rachmilewitz D, Branski D, Sharon P, Karmeli F: The possible role of endogenous prostanoids in the pathogenesis of peptic ulcer.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, A Allen, G Flemström, A Garner, W Silen, LA Turnberg (eds) New York, Raven Press, 1984, pp 329–333

    Google Scholar 

  119. Guth PH, Baumann H, Grossman MI, Aures D, Elashoff J: Measurement of gastric mucosal blood flow in man. Gastroenterology 74:831–834, 1978

    Google Scholar 

  120. Lam SK: Pathogenesis and pathophysiology of duodenal ulcer. Clin Gastroenterol 18:447–472, 1984

    Google Scholar 

  121. Thomas JM, Misiewicz G: Histamine H2 receptor antagonists in the short and long-term treatment of duodenal ulcer. Clin Gastroenterol 13:501–541, 1984

    Google Scholar 

  122. Hamilton I, Worsley BW, O'Connor HJ, Axon TR: Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer. Gut 24:1148–1151, 1983

    Google Scholar 

  123. Walan A, Bergsaker-Aspoy J, Farup P, Gillberg R, Halvorsen L, Kilander A, Lind T, Noesdal J, Offergaard S: Four week study of the rate of duodenal ulcer healing with omeprazole. Gut 24:A792, 1983

    Google Scholar 

  124. Howden CW, Forrest JAH, Reid JL: Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. Gut 25:707–710, 1984

    Google Scholar 

  125. Sachs G: Pump blockers and ulcer disease. N Engl J Med 310:785–786, 1984

    Google Scholar 

  126. Pounder RE: Duodenal ulcers that will not heal. Gut 25:697–702, 1984

    Google Scholar 

  127. Lam SK, Lee NW, Koo J, Hui WM, Fox KH, Ng M: Randomized crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine. Gut 25:703–706, 1984

    Google Scholar 

  128. Bardhan KD: Refractory duodenal ulcer. Gut 25:711–715, 1984

    Google Scholar 

  129. Malinowska DH, Sachs G: Cellular mechanisms of acid secretion. Clin Gastroenterol 13:322, 1984

    Google Scholar 

Download references

Author information

Affiliations

  1. Medicine and Physiology, University of Pennsylvania, 3400 Spruce Street, 19104, Philadelphia, Pennsylvania

    F. P. Brooks MD

Authors
  1. F. P. Brooks MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Brooks, F.P. The pathophysiology of peptic ulcer disease. Digest Dis Sci 30, 15S–29S (1985). https://doi.org/10.1007/BF01309381

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01309381

Keywords

  • Duodenal Ulcer
  • Gastric Ulcer
  • Peptic Ulcer Disease
  • Atrophic Gastritis
  • Mucosal Blood Flow